/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
The Supreme Court’s scathing remarks on prices charged by private hospitals have sent their stocks crashing. Whether this presents a great buying opportunity is open to debate.
Take a sector that has outperformed the market, even by the ongoing bull run’s standards. Add heightened private equity and primary market interest. Multiply this by a supply-constrained situation in which demand is booming. And did I mention that companies in this sector also get copious government support?
Like me, if you are offered an opportunity to invest in such a sector, you’ll probably say, “Just take my money”. Without a second thought. For years, most investors did exactly that with stocks of private corporate hospital chains such as Apollo Hospitals, Max Healthcare, Global Health (Medanta), Narayana Health and Fortis …
Vish Narain of Pulsar Capital on spotting real synergies between India and the Gulf, and why many entrepreneurs read the market wrong.
A public listing will help clean up the hospital chain’s balance sheet after the costly Sahyadri acquisition. But depressed metrics, integration risks and lofty valuations make this far from a clean turnaround story.
On the surface, Narayana Health’s latest acquisition holds promise. But a closer look suggests that the UK’s Practice Plus Group will need a bit of a turnaround before it can start yielding results.
